Koyfin Home > Directory > Health Care > Bristol-Myers Squibb Company > Cash from Financing Activities

Bristol-Myers Squibb Company Cash from Financing Activities Chart (BMY)

Bristol-Myers Squibb Company annual/quarterly Cash from Financing Activities from 2010 to 2020.
  • Bristol-Myers Squibb Company Cash from Financing Activities for the quarter ending June 06, 2020 was $-993m a 5.24% decrease of -52m year over year
  • Bristol-Myers Squibb Company Cash from Financing Activities for the last 12 months ending June 06, 2020 was $-10,665m a 238.02% decrease of -25,385m year over year
  • Bristol-Myers Squibb Company Annual Cash from Financing Activities for 2019 was $7,621m a 146.38% increase of 11,156m from 2018
  • Bristol-Myers Squibb Company Annual Cash from Financing Activities for 2018 was $-3,535m a -15.33% increase of 542m from 2017
  • Bristol-Myers Squibb Company Annual Cash from Financing Activities for 2017 was $-4,077m a 34.93% decrease of -1,424m from 2016
Other Cash Flow Metrics:
  • Bristol-Myers Squibb Company Cash Flow from Operations for the quarter ending September 09, 2018 was $1,279m a 12.67% increase of 162m year over year
  • Bristol-Myers Squibb Company Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $628m a -33.89% decrease of -213m year over year
  • Bristol-Myers Squibb Company Total Revenue for the quarter ending December 12, 2018 was $5,973m a 13.06% increase of 780m year over year
View Chart On Koyfin

Quarterly BMY Cash from Financing Activities Data

06/2020$-993m
03/2020$-1,054m
12/2019$-7,677m
09/2019$-941m
06/2019$18,268m
03/2019$-2,029m
12/2018$-578m
09/2018$-720m
06/2018$-1,015m
03/2018$-1,222m

Annual BMY Cash from Financing Activities Data

2019$7,621m
2018$-3,535m
2017$-4,077m
2016$-2,653m
2015$-3,624m
2014$-2,437m
2013$-1,068m
2012$-4,333m
2011$-2,657m
2010$-3,343m